103 related articles for article (PubMed ID: 25955824)
1. γ-Secretase inhibitor inhibits bladder cancer cell drug resistance and invasion by reducing epithelial-mesenchymal transition.
Wang Y; Wang G; Zhang X; Zhou X; Liu Z; Huang L; Liu R; Lang B; Xu X; Liu W; Fu L; Fu B
Mol Med Rep; 2015 Aug; 12(2):2821-7. PubMed ID: 25955824
[TBL] [Abstract][Full Text] [Related]
2. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097.
Wang L; Dai G; Yang J; Wu W; Zhang W
Med Sci Monit; 2018 Jun; 24():4046-4053. PubMed ID: 29899322
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
4. Gamma secretase inhibitor impairs epithelial-to-mesenchymal transition induced by TGF-β in ovarian tumor cell lines.
Pazos MC; Abramovich D; Bechis A; Accialini P; Parborell F; Tesone M; Irusta G
Mol Cell Endocrinol; 2017 Jan; 440():125-137. PubMed ID: 27908834
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical E-cadherin increase in 5FU-resistant colon cancer is unaffected during mesenchymal-epithelial reversion induced by γ-secretase inhibition.
Dinicola S; Pasqualato A; Proietti S; Masiello MG; Palombo A; Coluccia P; Canipari R; Catizone A; Ricci G; Harrath AH; Alwasel SH; Cucina A; Bizzarri M
Life Sci; 2016 Jan; 145():174-83. PubMed ID: 26746659
[TBL] [Abstract][Full Text] [Related]
6. miR-451 inhibits invasion and proliferation of bladder cancer by regulating EMT.
Zeng T; Peng L; Chao C; Fu B; Wang G; Wang Y; Zhu X
Int J Clin Exp Pathol; 2014; 7(11):7653-62. PubMed ID: 25550801
[TBL] [Abstract][Full Text] [Related]
7. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
8. TGFβ1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT.
Zhuang J; Lu Q; Shen B; Huang X; Shen L; Zheng X; Huang R; Yan J; Guo H
Sci Rep; 2015 Jul; 5():11924. PubMed ID: 26152796
[TBL] [Abstract][Full Text] [Related]
9. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
10. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of growth, migration and invasion of human bladder cancer cells by antrocin, a sesquiterpene lactone isolated from Antrodia cinnamomea, and its molecular mechanisms.
Chiu KY; Wu CC; Chia CH; Hsu SL; Tzeng YM
Cancer Lett; 2016 Apr; 373(2):174-84. PubMed ID: 26679052
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
13. Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1.
Zhang Y; Liu W; He W; Zhang Y; Deng X; Ma Y; Zeng J; Kou B
Int J Oncol; 2016 May; 48(5):2035-42. PubMed ID: 26983576
[TBL] [Abstract][Full Text] [Related]
14. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway.
Yang B; Huang J; Xiang T; Yin X; Luo X; Huang J; Luo F; Li H; Li H; Ren G
J Appl Toxicol; 2014 Jan; 34(1):105-12. PubMed ID: 24122885
[TBL] [Abstract][Full Text] [Related]
15. The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.
Guo C; Zhu K; Sun W; Yang B; Gu W; Luo J; Peng B; Zheng J
Biochem Biophys Res Commun; 2014 Jan; 443(4):1226-31. PubMed ID: 24393848
[TBL] [Abstract][Full Text] [Related]
16. Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
Jitao W; Jinchen H; Qingzuo L; Li C; Lei S; Jianming W; Zhenli G
Andrologia; 2014 Dec; 46(10):1128-33. PubMed ID: 24329492
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization.
Liu D; Qiu XY; Wu X; Hu DX; Li CY; Yu SB; Pan F; Chen XQ
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):165-172. PubMed ID: 29037814
[TBL] [Abstract][Full Text] [Related]
18. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
[TBL] [Abstract][Full Text] [Related]
20. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.
Cho SH; Park YS; Kim HJ; Kim CH; Lim SW; Huh JW; Lee JH; Kim HR
Int J Oncol; 2012 Jul; 41(1):211-8. PubMed ID: 22552741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
